Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for COVID-19 VACCINE, MRNA
- Immunogenicity After COVID-19 Vaccines in Adapted Schedules
- In-vivo Transmission Model in Semi-immune Adults
- Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino
- Prolonged Hypercoagulability Following Major Liver Resection for Malignancy
- Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
- Efficacy of Probiotics (LiveSpo Navax) in Preventing Respiratory Diseases in Children
- Antibiotics and Vaccine Immune Responses Study
- Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System
- HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia
- Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
- Safety and Immunogenicity of Ervebo® and Zabdeno® Booster Vaccines Against Ebola Virus Following Previous Vaccination With the Zabdeno/Mvabea® or Ervebo® Vaccine Schedules in DRC
- Efficacy and Safety of Carica Papaya in Dengue Fever: A Randomised Clinical Trial
- Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
- Phase 3 Open-Label Controlled Trial of Convalescent Plasma in Early COVID-19 Infection
- Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
- Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
- Role of Vitamin D in Prevention of Dengue Haemorrhagic Fever and Dengue Shock Syndrome
- Mass Vaccine and Drug Administration, Bangladesh
- CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
- Systems Biological Assessment of Statin Effect on Vaccine Responses
- Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma
- Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer
- A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo
- Intratumoral PH-762 for Cutaneous Carcinoma
- EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer
- Safety, Reactogenicity and Immunogenicity of a Venezuelan Equine Encephalitis DNA Vaccine Candidate Administered by Jet Injection
- Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal Cancer
- AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma
- Shigella Sonnei 53G Human Infection Study in Kenyan Adults
- FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined With Immune Checkpoint Inhibition
- Study of the Plasmodium Vivax Transmission-blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-blocking Activity in Healthy Malaria-naive Adults
- Combining Intratumoral Flu Vaccine and Systemic Pembrolizumab in Patients With Early pMMR Colorectal Cancer
- Pan-Malaria Transmission-Blocking Vaccine AnAPN1
- Efficacy and Safety of Hepatitis B Virus Vaccine(HBV) in Treatment of Cutaneous Warts
- Yellow Fever Human Infection Model With YF-17D
- A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD)
- Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer
- TEIPP Immunotherapy in Patients With NSCLC
- A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa
- A Clinical Trial to Evaluate the Safety and Immunogenicity of a Prophylactic HIV Vaccine Candidate
- PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway
- A Study to Evaluate ATP150/ATP152, VSV-GP154 and Ezabenlimab in Patients With KRAS G12D/G12V Mutated PDAC (KISIMA-02)
- Safety, Tolerability and Immunogenicity of Alveavax-v1.2, a BA.2/Omicron-optimized, DNA Vaccine for COVID-19 Prevention
- Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104
- Addition of Everolimus to Standard of Care in Carcinoma Gallbladder
- A Placebo Controlled Clinical Trial Investigating the Safety and Immunogenicity of GBS6 in Pregnant Women
- Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1
- A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy Participants
- Clinical Trail of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) as Booster in Participants Aged 18 Years and Older
- Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma
- Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer
- A Study to Learn Whether Respiratory Syncytial Virus (RSV) and Flu Vaccines Given Together as a Single Shot Work as Well as When Given Separately
- Trivalent Salmonella Conjugate Vaccine (TSCV)
- Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding NP-GT8 and IL-12, With or Without a TLR-agonist-Adjuvanted HIV Env Trimer 4571 Boost, in Adults Without HIV
- Shingrix In Recipients of Allogeneic Transplants
- Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Gastric Cancer
- Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma
- Clinical Study of mRNA Vaccine in Patients With Liver Cancer After Operation
- A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine
- Using Neoantigen Peptide Vaccine/Neoantigen-based DC to Treat Advanced Malignant Solid Tumors
- Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT
- Clinical Trial of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over
- A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months
- Evaluation of Safety and Immunogenicity of rVSVΔG-SEBOV-GP Vaccine in Adults With Good General Health
- Nivolumab With Ipilimumab Combined With TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic Cancer
- Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2
- PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma
- The COMBAT HBV Feasibility Trial
- Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)
- Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008)
- Phase I Open Label Clinical Trial Using Resiniferatoxin, A Non-Opioid Medication, for the Management of Refractory Morton's Neuroma Pain
- Trial to Model Primary, Secondary, and Tertiary Dengue Using a Monovalent Vaccine
- Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed o6-methylguanine-DNA-methyltransferase (MGMT) Negative Glioblastoma Multiforme (GBM)
- Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons
- Safety, Tolerability and Immunogenicity of a Novel Inactivated Whole-cell Pneumococcal Vaccine Gamma PN-3.
- Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant Recipients
- Phase 1/2a Study of BLB-201 Vaccine in RSV Seronegative and Seropositive Infants and Children
- Phase 1 Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)
- Randomized Phase II Evaluation of a Cancer Lysate Vaccine and Montanide (Registered) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for Non-Small Cell Lung Cancer
- Follow-up and Steroid Treatment Results in Intussusception
- Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic Cancer
- Combination of CAR-DC Vaccine and PD-1 Antibody in Local Advanced/Metastatic Solid Tumors
- Combination of CAR-DC Vaccine and PD-1 Antibody in Malignant Tumors
- A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers
- Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study
- ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
- A Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as Booster
- A Phase I/II Study of GLB-COV2-043 as a COVID-19 Vaccine Booster
- Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines
- A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50-59 Years of Age, Including Adults at Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease, Compared to Older Adult
- EO4010 in Previously Treated Metastatic Colorectal Carcinoma
- JT001 (VV116) for the Treatment of COVID-19
- Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR
- A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS
- Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients
- Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- A Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in China
- A Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in Chinese People
- A Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Over in China
- A Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants in China
- Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa
- Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- Phase 2 Study of the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine
- Phase 2a Trial to Evaluate Safety and Immunogenicity of COVID-19 Vaccine Strategies in HIV-infected/Uninfected Adults.
- Recombinant, Bivalent, Norovirus Vaccine Study
- Safety and Immunogenicity of CJCV2 With and Without ALFQ
- Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile
- A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever
- A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients
- Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults
- Pertussis Challenge Study in Adults Vaccinated With BPZE1
- Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant
- Study of an Individualized Vaccine Targeting Neoantigens in Combination With Immune Checkpoint Blockade for Patients With Colon Cancer
- Inactive HBsAg Carriers (IHCs) Treated With Pegylated Interferon α2b Based Intervention Therapy
- Topical Antibacterial Agents for Prevention of COVID-19
- A Phase II Study of N-803 Alone or in Combination With BN-Brachyury Vaccine or Bintrafusp Alfa (M7824) for Participants With Castration Resistant Prostate Cancer
- A Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment of Myeloproliferative Neoplasms
- Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adults
- Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2
- Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents
- Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and People Living With Human Immunodeficiency Virus (HIV)
- Study To Evaluate The Safety, Tolerability And Immunogenicity Of 4 mg Of ITI-3000 In Patients With Polyomavirus-Positive Merkel Cell Carcinoma (MCC)
- Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome
- Phase 1 Trial for Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Oral Shigella/ETEC Combination Vaccine to Healthy Adults
- Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant Women
- Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer
- Effects of Nasal-spraying LiveSpo Navax in Treatment of Influenza Virus in Children
- Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine
- A Study Assessing the Safety, Tolerability, Immunogenicity of COVID-19 Vaccine Candidate PRIME-2-CoV_Beta, Orf Virus Expressing SARS-CoV_2 Spike and Nucleocapsid Proteins (ORFEUS)
- ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab
- A Study of COVID-19 mRNA Vaccine (SYS6006) in Chinese Healthy Adults Aged 18 -59 Years.
- A Study of COVID-19 mRNA Vaccine (SYS6006) in Chinese Healthy Older Adults.
- EO2040 in Combination With Nivolumab, for Treatment of Patients With Minimal Residual Disease of Colorectal Cancer
- Persistent Readiness Through Early Prediction Immunization Study
- A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age
- BCG Revaccination in Children and Adolescents
- Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old, An Exploratory Immunogenicity Study
- A Study of Various Respiratory Syncytial Virus (RSV) Pre-Fusion (preF)-Based Vaccine Formulations in Adults Aged 60 Years and Older
- Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab
- Homologous vs Heterologous Third Vaccination in Kidney Transplant Recipients Kidney Transplant Recipients
- Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD): SICA 2: SPECIFIC SIGNALING INHIBITOR IN CANNABIS ADDICTION
- Establishing Immunogenicity and Safety of Needle-free Intradermal Delivery of mRNA COVID-19 Vaccine
- Influenza Vaccine With Topical Imiquimod in Influenza Vaccine Non-responsive Children
- Study of EVX-01 Vaccine in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma
- The Immunostimulatory Effects of Gentamicin
- Paediatric VLA2001-321 Study
- A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Vaccine Against HSV-2 in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent HSV-2 Genital Herpes
- Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae
- Efficacy of the Vacucis Candida® Autovaccine
- COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial)
- Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study
- ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM
- Phase I/II, Open-label Dose-Escalation Randomized Study of High-Dose mRNA-1273 Booster for Lung Transplant Recipients
- Add-on Study on Solidarity Trial Plus in Nepal
- Safety, Tolerability and Immunogenicity of Recombinant COVID-19 Vaccine Betuvax-CoV-2
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors, The PNeoVCA Study
- Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women
- KRAS-Targeted Vaccine With Nivolumab and Ipilimumab for Patients With NSCLC
- Safety and Immunogenicity of the Malaria Vaccine, R21/MatrixM, in Healthy Thai Adults
- Phase 3 Study to Evaluate a Single Booster of the NVX-CoV2373 COVID19 Vaccine in Adults
- Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.
- Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer
- Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in COVID-19 Patients With ARDS
- ALACOVID Study for Vaccinated Subjects
- A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in India
- Safety and Immunogenicity Study of EgyVax Vaccine Candidate for Prophylaxis of COVID-19 Infection
- Pilot Study Evaluating the Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers
- Preservation and Transfer of HBV Immunity After Allogeneic HSCT for SCD.
- A Study of Neoantigen mRNA Personalised Cancer in Patients With Advanced Solid Tumors
- Personalized DC Vaccines in Non Small Cell Lung Cancer
- Safety and Immunogenicity of 2 Doses Versus 1 Dose of Acellular Pertussis Vaccines Containing Genetically-detoxified Pertussis Toxin in Young Adults Previously Primed With Acellular Pertussis Vaccines
- Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Trial
- Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID in Healthy Adult Volunteers
- A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult Participants
- GLS-5310 Vaccine in Healthy Volunteers as a Booster for SARS-CoV-2 (COVID-19)
- A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.
- Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults
- Vaccine Responses in Patients With B Cell Malignancies
- Effects of Nasal-spraying LiveSpo Navax in Treatment of Acute Respiratory Infections in Children
- Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer
- A Phase I/II Study of Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers
- A Study of a Personalized Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer
- TA-CIN Vaccine With Anti-PD-1 Therapy in Recurrent HPV16-associated Cancers
- Safety, Tolerability, and Immunogenicity of ORI-A-ce001 for the Treatment of Acne Vulgaris
- A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal Cancer
- Autologous Dendritic Cell Vaccine in Kidney Cancer
- A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age
- A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection
- Immunotherapy Combined With Radiation and Influenza Vaccine for Pancreatic Cancer.
- Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma or Hormone Receptor Positive Her2 Negative Metastatic Refractory Breast Cancer
- PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Reactogenicity and Immunogenicity of Third Dose Vaccine Booster Following Two Doses of Inactivated Vaccines
- A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults
- COVID-19 VaccinE Response in Rheumatology Patients
- COVID Protection After Transplant-Immunosuppression Reduction
- Tolerability and Efficacy of UV1 Vaccine in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Planned for First-line Treatment With Pembrolizumab
- A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants
- Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2
- A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine
- Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma
- Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients
- Efficacy and Safety of Baricitinib in Patients With Moderate and Severe COVID-19
- Feasibility of Randomizing Danish Citizens Aged 65-79 Years to High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in a Pragmatic Registry-Based Setting
- Masitinib in Patients With Symptomatic Mild to Moderate COVID-19
- A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pre
- Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization
- Assessing Durable Antibody Response to HPV Vaccination
- COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies
- Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimen
- Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine
- Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines.
- Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm
- Neoantigen-expanded Autologous Immune Cell Therapy
- VRC 614: A Phase 1, Dose Escalation, Open-Label Clinical Trial With Experimental Controlled Human Malaria Infections (CHMI) to Evaluate Safety and Protective Efficacy of an Anti-Malaria Human Monoclonal Antibody, VRC-MALMAB0114-00-AB (L9LS), in Heal
- A Trial of Novaferon in Asymptomatic or Mild COVID-19 Patients
- Mutant Kirsten Rat Sarcoma (KRAS) -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
- Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients
- Safety and Efficacy Evaluation of the P2Et Extract in Patients With Breast Cancer
- COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
- Stop Hep B @ Birth
- Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine Booster
- Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine.
- Androgen Deprivation, With or Without pTVG-AR, and With or Without Nivolumab, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
- Tafenoquine and Primaquine in Colostrum and Breast Milk
- Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population
- A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers
- Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)
- Third Dose of COVID-19 Vaccine in LTCF Residents
- Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery
- Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes
- Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)
- rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
- Prevention of Acute Respiratory Infection in Taiwanese Institutionalized Elderly
- A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
- Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2, the Causative Agent of COVID-19
- NeoVax + CDX-301 and Nivolumab in Advanced Melanoma
- Study About the Response to the Administration of a Third Dose of mRNA-1273 Vaccine (COVID-19 Vaccine Moderna) in Renal Transplants With Immunological Failure Initial to Vaccination
- A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years
- Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals
- Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
- Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19.
- First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV, in Healthy Adults
- Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer
- Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above
- A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and Adults
- A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
- Immunogenicity After Revaccination With 23-valent Pneumococcal Polysaccharide Vaccine: Healthy Elderly People Versus Diabetic Patients
- PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V
- Experimental Human Infection With Neisseria Gonorrhoeae (LptA Trial)
- Efficacy, Immunogenicity and Safety Study of GSKs Recombinant Zoster Vaccine Shingrix (GSK1437173A) in Chinese Adults Aged ≥50 Years
- Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab
- SARS-CoV-2 Human Challenge Characterisation Study
- AST-021p Study in Advanced Solid Tumors
- Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors
- Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19
- COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers
- Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B
- The Effects of Acupuncture in Overcoming Inflammatory Response to COVID-19 Mild-moderate Symptoms
- TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
- A Study to Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in Kenya
- Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants
- Prophylaxis Vaccine Antibodies Ebola
- STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19
- A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas
- An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older
- Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine
- Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer
- A Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-LASV-GPC Vaccine in Adults in Good General Heath
- Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC)
- A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older
- SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 in Healthy Adults
- Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults
- Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis
- A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years
- Impact of Colchicine and Low-dose Naltrexone on COVID-19
- Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults
- Dose Escalation Study of Immunomodulatory Nanoparticles
- Investigator-initiated Clinical Trial (Phase II) of Cancer Vaccine "Dainippon Sumitomo Phama(DSP)-7888" for Acute Myeloid Leukemia Patients.
- Enriched Heparin Anti COVID-19 Trial
- Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian
- Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety.
- Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE
- VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers
- Complement Regulation to Undo Systemic Harm in Preeclampsia
- Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis
- Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19
- An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions
- Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults
- Non Inferiority Trial of Locally Manufactured Rabies Vaccine 'Rabix-VC' in Bangladesh
- OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC
- Ad26.ZEBOV Booster in Children Previously Vaccinated With Ad26.ZEBOV and MVA-BN-Filo (EBOVAC Booster Study)
- Sargramostim Use in COVID-19 to Recover Patient Health
- Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine
- Reducing Vertical Transmission of Hepatitis B in Africa
- NORTH-REG Dwell-Time Study
- HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB)
- Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza.
- Safety and Efficacy of BARS13 in the Elderly
- A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19
- A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma
- Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic
- A Multicenter Study to Assess Response to Influenza Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
- Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults
- Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality?
- Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland
- Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy
- Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma
- Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure
- A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19
- Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults
- Phase 2 Study to Evaluate PVX-410 + Pembrolizumab + Chemotherapy for Metastatic, PD-L1+ Triple-Negative Breast Cancer
- Use of Angiotensin-(1-7) in COVID-19
- BCG Vaccination to Prevent COVID-19
- CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2)
- A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)
- Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19
- Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection?
- A Phase III Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers
- Ivermectin in Adults With Severe COVID-19.
- Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)
- Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19
- Intratumoral Influenza Vaccine for Early Colorectal Cancer
- Efficacy of Nicotine in Preventing COVID-19 Infection
- A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial
- Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 : An Innovative Therapeutic Approach COVID-19
- Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta "Trap"/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT)
- Primary TBE Vaccination for the Elderly
- Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19
- Study of AZD1222 for the Prevention of COVID-19 in Japan
- Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer Treatment
- Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asia
- A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19
- Estrogen Therapy in Non-severe COVID-19 Patients
- Virtual Reality MObility for Burn Patients
- Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
- COVID-19: Collecting Measurements of Renin-angiotensin-system Markers, Such as Angiotensin-2 and Angiotensin 1-7
- BCG Against Covid-19 for Prevention and Amelioration of Severity Trial (BAC to the PAST)
- Influenza Vaccine in Lung Transplant Patients - Antibody
- Influenza Vaccine in Lung Transplant Patients - T Cells
- Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies
- Influenza Vaccine in Lung Transplant Patients - Seroprotection
- Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season
- Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment
- A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive
- Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel
- Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection
- Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma
- Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents
- Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia
- Ivermectin Nasal Spray for COVID19 Patients
- COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)
- Study to Assess Effectiveness of GlaxoSmithKline's (GSK's) Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults.
- Phase II Trial of Combination Immunotherapy in Subjects With Advanced Small Bowel and Colorectal Cancers
- A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination. (V419-013)
- Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer
- Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection
- Clinical Study of Neoantigen Vaccine Combined With Targeted Drugs in the Treatment of Non-small Cell Lung Cancer
- Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection
- Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC
- Efficacy and Safety of Sirolimus in COVID-19 Infection
- PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention Trial
- Immunogenicity of an Anti-pneumococcal Combined Vaccination in Acute Leukemia or Lymphoma
- Study of the Impact of a School Program Combining - Promotion of HPV Vaccination and HPV Vaccine Offer in Middle School - on Adherence to HPV Vaccination in Middle School Students
- Clinical Trials of Multivalent Opioid Vaccine Components
- Study of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1
- Immunization With BCG Vaccine to Prevent Tuberculosis Infection
- Hesperidin and Diosmin for Treatment of COVID-19
- A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults
- Control of COVID-19 Outbreaks in Long Term Care
- Dose Escalation Study Assessing the Safety and Immune Response of PPV-06 Vaccine
- Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults
- Universal Anti-Viral Vaccine for Healthy Elderly Adults
- Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients
- A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19
- A Comparative Study to Assess Efficacy of Intralesional MMR Vaccine and Intralesional Vitamin D3 in Treatment of Warts
- Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients
- The Safety & Efficacy of Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia
- Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine (GSK3878858A) When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 50 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI)
- Breast Cancer Vaccine in Combination With Pembrolizumab for Treatment of Persistent, Recurrent, or Metastatic Breast Cancer
- Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19
- VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination
- A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC
- Phase I Study of Individualized Neoantigen Peptides in the Treatment of EGFR Mutant Non-small Cell Lung Cancer
- Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization
- Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer
- Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment
- New Antiviral Drugs for Treatment of COVID-19
- A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection
- Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19
- Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection
- PROphylaxis for paTiEnts at Risk of COVID-19 infecTion
- Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.
- Favipiravir vs Hydroxychloroquine vs Control in COVID -19
- Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19
- PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy)
- Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19
- Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2
- Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19
- Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients
- Clinical Application of Methylene Blue for Treatment of Covid-19 Patients
- HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma
- INO 5401 Vaccination in BRCA1/2 Mutation Carriers
- Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma
- Safety, Tolerability and Immunogenicity of MVA.HTI and ChAdOx1.HTI With Vesatolimod in HIV-1 Positive Patients
- Combinatorial Therapy to Induce an HIV Remission
- Measles Vaccine in HCW
- Administration of Chlorpromazine as a Treatment for COVID-19
- Dendritic Cell Vaccines Against Her2/Her3, Cytokine Modulation Regimen, and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19
- Direct Injection of Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma
- Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers
- Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort
- Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers
- Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel
- CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION
- Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study
- Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial
- Convalescent Plasma for Patients With COVID-19: A Pilot Study
- Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19)
- Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer
- The Vietnam Chloroquine Treatment on COVID-19
- Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine
- BCG Vaccination to Protect Healthcare Workers Against COVID-19
- Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection
- A Study of a Candidate COVID-19 Vaccine (COV001)
- Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.
- Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Extension Study
- Study to Assess the Immunogenicity and Safety of GSK's Meningococcal Group B Vaccine When Administered Concomitantly With GSK's Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age
- "Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma
- Trial of Treatments for COVID-19 in Hospitalized Adults
- NO Prevention of COVID-19 for Healthcare Providers
- An Inflammatory Challenge Using Endotoxin
- BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)
- Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma
- Controlled Human Malaria Infection Transmission Model - Phase A
- The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19
- Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab
- Topical Curcumin for HPV Related Cervical Disease
- Evaluation of UCPVax Plus Nivolumab as Second Line Therapy in Advanced Non Small Cell Lung Cancer
- Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19
- Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19
- GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC
- DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma
- Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection
- GVAX Plus Checkpoint Blockade in Neuroblastoma
- Improving Care Through Azithromycin Research for Infants in Africa
- Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-HZ in Healthy Adult Volunteers
- Trial to Evaluate CIS43LS in Healthy Adults
- A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Comparative Study - (ECG-CHMI)
- Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
- Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer
- A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma
- Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination
- A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (pPCV) in Adults
- Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection
- Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy
- Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery
- Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness Patients
- A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women
- HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
- Study of Safety and Immunogenicity of BVRS-GamVac-Combi
- Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their Infants
- Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected MMR-p Colorectal and Pancreatic Cancer
- Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B.
- DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr
- B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
- Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer
- Polarized Dendritic Cell (aDC1) Vaccine, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma
- A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) Who Had Prior Episode of Shingles
- A Study to Test GlaxoSmithKline's (GSK) Respiratory Syncytial Virus RSV Candidate Vaccine's Safety and Immune Response in Japanese Older Adults
- pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer
- Induction of Gut Permeability by an Oral Vaccine
- A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma
- Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study
- A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP
- A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy Adults
- Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation
- Dual Vaccine Trial in Myeloproliferative Neoplasms
- DNA Vaccination Against Neuroblastoma
- Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer
- Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma
- Evaluate the Efficacy and Safety of GV1001 in Patients With Benign Prostatic Hyperplasia (BPH)
- ZEBOVAC (Ebola Vaccine Trial, Ad26.ZEBOV/MVA-BN-Filo)
- Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years
- NeoVax With Nivolumab in Patients With Ovarian Cancer
- Application of a TBE-Vaccine in Obese Persons
- Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026)
- Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma
- Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients
- Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023)
- Vaccination Efficacy With Metformin in Older Adults
- Vitamin D3 For CGD Patients With BCGosis/Itis
- Blood Donor CVD 5000
- Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC
- CVD 37000: Immunity and Microbiome Studies at Intestinal and Systemic Sites in Ty21a Vaccinated Adults
- Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households
- Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
- Sanaria PfSPZ Challenge With Pyrimethamine or Chloroquine Chemoprophylaxis Vaccination (PfSPZ-CVac Approach): A Randomized Double Blind Placebo Controlled Phase I/II Trial to Determine Safety and Protective Efficacy Against Natural Plasmodium Falcip
- HPV-SAVE: 9-Valent HPV Vaccine for High-Grade Anal Dysplasia
- Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)
- Flublok or Fluzone With Advax-CpG55.2 or AF03
- A Study of Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects
- Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma
- Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma
- Pfs230D1M-EPA/AS01 Vaccine, a Transmission Blocking Vaccine Against Plasmodium Falciparum, in an Age De-Escalation Trial of Children and a Family Compound Trial in Mali
- Treatment and Vaccine Development of Mycoplasma Pneumoniae
- A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine
- An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)
- A Study to Evaluate the Antibody Response of Influenza Vaccination Following Concomitant Exposure to Bimekizumab in Healthy Subjects
- AMPLIFYing NEOepitope-specific VACcine Responses in Progressive Diffuse Glioma
- Bacille Calmette-Guérin (BCG) Vaccine In Radiologically Isolated Syndrome (RIS)
- Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults
- Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors
- Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG
- A Study to Evaluate the Reactogenicity, Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' HBV (Hepatitis B Virus) Viral Vector Vaccines and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B
- Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected Patients
- Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection
- Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts
- Impact on Disease Relapse of HPV Vaccination in Women Treated With LEEP for Cervical Intraepithelial Neoplasia. HOPE9
- Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to AD
- VAccination in Early and ADvanced Prostate caNCEr
- A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults
- Converting HR+ Breast Cancer Into an Individualized Vaccine
- Pneumococcal Conjugate Vaccine in Aging Renal Transplant
- Anti-Schistosomiasis Vaccine: Sm14 Phase 2b-Sn in School Children
- JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
- Vaccination With Flt3L, Radiation, and Poly-ICLC
- A Phase 2, Double-blind Study to Evaluate Immunogenicity and Safety of Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult Volunteers
- Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer - a Combination Immunotherapy Phase Ib Study.
- Dendritic Cell (DC)/Myeloma Fusions in Combination With Nivolumab in Patients With Relapsed Multiple Myeloma
- MG1-MAGEA3 With Ad-MAGEA3 and Pembrolizumab in Patients With Previously Treated Metastatic Melanoma or Cutaneous Squamous Cell Carcinoma
- Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors
- Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
- A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein D
- Bordetella Pertussis Colonisation Challenge Study
- Analysis of Antigen Specific B Cell Responses to Immunization With Influenza Virus Vaccine
- Safety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic Melanoma
- 2017 A/H7N9 IIV Revaccination
- Humoral Immunodeficiency in CLL and Therapy With Subcutaneous Ig
- Blood Donor CVD 9000
- Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects
- Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac)
- Impact of Metformin on Immunity
- CVD 38000: Study of Responses to Vaccination With Typhoid and/or Cholera
- FLUAD vs. FLUZONE HD Influenza Vaccine in Residents of Long Term Care
- DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
- Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza
- Dendritic Cell/AML Fusion Cell Vaccine Following Allogeneic Transplantation in AML Patients
- Community Health Azithromycin Trial in Burkina Faso
- A Study to Evaluate Different Dose Levels of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3888550A), Based on the Vaccine Safety and the Antibodies (Body Defences) Produced Following Vaccine Admini
- A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC
- Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma
- Non-specific Effects of Rabies Vaccine
- A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96
- QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma.
- Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV
- Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine
- Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma
- Inducing Immune Quiescence the Genital Tract With ASA
- MER3101: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes
- Conditioning SCID Infants Diagnosed Early
- Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
- Vaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV Melanoma
- Testing the Addition of an Individualized Vaccine to Nab-Paclitaxel, Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
- Influenza Vaccine Responses
- pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer
- PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell Carcinoma
- DC Vaccine in Pancreatic Cancer
- 2013/2017 H7N9 Prime-Boost Interval
- QUILT-3.080: NANT Pancreatic Cancer Vaccine
- Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers
- Arresting Vertical Transmission of Hepatitis B Virus
- QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine
- QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
- QUILT-3.088: NANT Pancreatic Cancer Vaccine
- Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
- Systems Biology of Inactivated Rabies Vaccine in Healthy Adults With or Without Use of Broad Spectrum Antibiotics
- QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine
- Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy
- A Study to Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer
- Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients With PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies
- UV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma
- Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer
- An Extension Study of V203-AD Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UB-311
- A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults
- BARDA Securing Anthrax Immunity For the Elderly
- Safety, Immunogenicity, and Protective Efficacy of Two Regimens of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Natural Transmission Season in Healthy African Adults in Mali
- Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria
- Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
- V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)
- The Efficacy of Intra-lesional Bleomycin Versus Intra-lesional Purified Protein Derivative in Treatment of Palmoplantar Warts
- Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission
- H5N1 With or Without Topical Aldara in Healthy Adults
- The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After Discontinuation
- A First-In-Human Study to Evaluate Safety, Tolerability, Reactogenicity, and Immunogenicity of JNJ-64300535, a DNA Vaccine, Administered by Electroporation-Mediated Intramuscular Injection, in Participants With Chronic Hepatitis B Who Are on Stable
- Postpartum HPV Vaccination
- Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma
- Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in Humans
- Vaccine + Durvalumab in Human Papilloma Virus (HPV) Cancers
- 3VM1001 Cream for the Treatment of Pain Associated With Post Herpetic Neuralgia (PHN)
- HPV Anti-CD40 RNA Vaccine
- Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)
- HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAg
- Impact of a Fourth Hexavalent Vaccine After Hematopoietic Stem Cell Transplantation
- Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma
- Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)
- HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer
- QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed
- QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
- QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.
- Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer
- Allogeneic Myeloma GM-CSF Vaccine With Lenalidomide in Multiple Myeloma Patients in Complete or Near Complete Remission
- PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer
- Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma
- Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer
- DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Safety, Immunogenicity and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy Adult Participants
- Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B Infection
- Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas
- Phase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer
- Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B Patients
- QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
- Western Australian Pre-exposure Prophylaxis for HIV Implementation Trial
- T-Cell Infusion, Aldesleukin, and Utomilumab in Treating Patients With Recurrent Ovarian Cancer
- Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4
- Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly
- A Study to Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of Age
- Improved Novel VaccIne CombinaTion InflUenza Study
- PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma
- MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial
- The Immune Response to Influenza Vaccinations in Elderly Individuals
- Safety and Effectiveness of BPL HRIG With Active Rabies Vaccine in Healthy Subjects
- MMF for HIV Reservoir Reduction
- Immunologic Responses to a Live Attenuated Oral Cholera Vaccine
- Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis
- Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC
- UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.
- Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
- A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.
- Humoral Immunodeficiency With Rituximab and Therapy With Subcutaneous Ig
- Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Safety and Immunogenicity Study of DNA.HTI, MVA.HTI and ChAdOx1.HTI in HIV-1-positive Patients (AELIX-002)
- IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients
- A Long Term Follow-up Study up to 4 Years After Study Vaccination to Assess Immunogenicity and Safety of the Investigational Vaccine in Adults
- Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy
- QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy
- QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
- A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the GlaxoSmithKline (GSK) Biologicals' Respiratory Syncytial Virus (RSV) Investigational Vaccine (GSK3003891A) in Healthy Pregnant Women and Infants Born to Vaccinated Mothers
- Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer
- TSA-DC Vaccine in Treating Patients With Gastrointestinal Solid Tumor
- Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts
- Enhancing Preventive Therapy of Malaria In Children With Sickle Cell Anemia in East Africa (EPiTOMISE)
- QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy
- Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection
- QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL
- QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC
- QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
- QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors
- Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus
- QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy
- QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy
- Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer
- Phase 1/2 Study of Combination Immunotherapy and mRNA Vaccine in Subjects With NSCLC
- The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer
- Safety and Efficacy of MEDI0457 and Durvalumab in Patients With HPV Associated Recurrent/Metastatic Head and Neck Cancer
- GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer
- Study of Biomarkers of Immune Activation Associated With Symptoms and Immune Responses After Influenza Vaccination in Adults
- Safety and Immunogenicity Study of GX-70 in TB Patient
- Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas
- Avelumab Plus Autologous Dendritic Cell Vaccine in Pre-treated Metastatic Colorectal Cancer Patients
- Accelerated Vaccination Schedule Against Hepatitis B Virus With Combined Hepatitis A and B Vaccine Among Hemodialysis Patients
- Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ)
- QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
- Effectiveness of Alcohol Swabs for Preventing Infections During Vaccination
- Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma
- Yellow Fever Vaccine on Statin/ Non Statin Subjects
- Dendritic Cell Vaccination in Patients With Advanced Melanoma
- Dose Escalation PfSPZ-CVac
- Immunity to Hepatitis B Vaccine
- Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer
- Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy
- Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors
- Study of Sting Challenge and Serological Responses to Jack Jumper Venom Immunotherapy With Inulin as Adjuvant (Jumpvax)
- Entolimod, an Adjuvant for Vaccine Augmentation
- DC/AML Fusion Cell Vaccine vs DC/AML Fusion Cell Vaccine Plus Durvalumab vs Observation in Patients Who Achieve a Chemotherapy-induced Remission
- Two Doses of Multimeric-001 (M-001) Followed by Two Doses of an Influenza A/H7N9 Vaccine
- Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004
- Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults
- Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanoma
- Study of Safety and Immune Response of the Sm14 Vaccine in Adults of Endemic Regions
- Safety and Therapeutic Efficacy of mAb VRC01 During ATI in Early Treatment During Acute HIV Infection
- Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer
- IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery
- Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer
- Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
- H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology
- Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer
- Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer
- The P10s-PADRE Basket Trial: Vaccination of Metastatic Cancer Patients
- Trial of Perioperative Tadalafil and Influenza Vaccination in Cancer Patients Undergoing Major Surgical Resection of a Primary Abdominal Malignancy
- Safety and Efficacy of Sanaria's PfSPZ-CVac in Malian Adults
- Safety, Tolerability, and Immunogenicity of One Dose of NDV 3A Vaccine in People With STAT3-Mutated Hyper-IgE Syndrome
- Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus
- Evaluation of the Implementation and Effectiveness of IPP-HPV
- Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours
- The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity
- LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy
- Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
- Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer
- A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia
- An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection
- Influenza Vaccine Feasibility Study in Children With Persistent Asthma
- Imiquimod and Influenza Vaccine for Immunocompromised Patients
- H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas
- A Study to Rank Different Dosages of Antigen of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A), Based on Their Immune Response and Safety, When Administered to Healthy Adult Women
- ZIKA Vaccine in Naive Subjects
- NeoVax Plus Ipilimumab in Renal Cell Carcinoma
- Evaluation of Dupilumab in Children With Uncontrolled Asthma
- Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant
- Topical Curcumin for Precancer Cervical Lesions
- Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali
- Optimising Rotavirus Vaccine in Aboriginal Children
- Vaccination of Triple Negative Breast Cancer Patients
- PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer
- A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants
- Study of Single IV Administration of P2G12
- H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses
- Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.
- Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults
- Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies
- A Safety and Efficacy Study of R21 +/- ChAd63/MVA ME-TRAP
- 2-week dc of MTX and Influenza Vaccination in RA
- A Study of a New Leishmania Vaccine Candidate ChAd63-KH
- A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM
- Effect of mTOR Inhibition and Other Metabolism Modulating Interventions on the Elderly
- Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine
- Safety of Nasal Influenza Immunisation in Children With Asthma
- Safety and Tolerability Evaluation Study of BVAC-C in Patients With HPV Type 16 or 18 Positive Cervical Cancer
- Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer
- Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
- Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)
- A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membra
- Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)
- A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls
- Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)
- Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults
- Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer
- Universal Cancer Peptide-based Vaccination in Metastatic NSCLC
- Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma
- Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation
- iVAC-CLL01: Patient-individualized Peptide Vaccination After First Line Therapy of CLL
- A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer
- Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
- Docetaxel Followed by Provenge in Metastatic Prostate Cancer
- Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer
- Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV[Delta]G-ZEBOV-GP) for Pre-Exposure Prophylaxis (PREP) in People at Potential Occupational Risk for Ebola Virus Exposure
- Safety, Tolerability and Immunogenicity Study of Different Vaccine Regimens of Trivalent Ad26.Mos.HIV or Tetravalent Ad26.Mos4.HIV Along With Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults
- Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
- Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer
- Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1
- PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United States
- Randomized Controlled Trial of ProstAtak® Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
- Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)
- Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh.
- A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma
- Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML
- A Study to Evaluate the Safety and Immunogenicity of Different Doses of ExPEC4V (JNJ-63871860) in Healthy Japanese Adult Participants
- MTX Discontinuation and Vaccine Response
- Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
- Immunogenicity and Safety of the Seasonal Flu Vaccine in Elderly and in SOT Recipients
- A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers
- A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer
- Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401)
- Cardio-respiratory Events and Inflammatory Response After Primary Immunization in Preterm Infants
- Ciprofloxacin for the Prevention of Meningococcal Meningitis
- Safety and Immunogenicity of Personalized Genomic Vaccine to Treat Malignancies
- VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma
- Acupuncture for Prevention of Recurrent Urinary Tract Infections.
- Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation
- Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL
- Safety, Tolerability and Immunogenicity Study of Different Vaccine Schedules With Ad26.Mos.HIV and Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults
- Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Diseas
- Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC
- Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol
- Safety and Immunogenicity of Sanaria's Irradiated Sporozoite Vaccine (PfSPZ Vaccine) in Malaria-Experienced Adults in Burkina Faso
- Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population
- A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients
- Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer
- Study With CY, Pembrolizumab, GVAX, and SBRT in Patients With Locally Advanced Pancreatic Cancer
- A Pilot Study of the Safety, Tolerability, and Effectiveness of Halo
- Vigil™ + Nivolumab in Advanced Non-Small Cell Lung Cancer
- Sequential Versus Simultaneous Pneumococcal Vaccination in Elderly: Immunological Memory and Antibody Levels
- Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer
- Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites in Healthy African Adults in Mali
- Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck
- Immune Response to Shingles Vaccination
- Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients
- H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
- Study to Evaluate the Safety and Effect of HIVconsv Vaccines in Combination With Histone Deacetylase Inhibitor Romidepsin on the Viral Rebound Kinetic After Treatment Interruption in Early Treated HIV-1 Infected Individuals
- A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR)
- A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB
- A Study of Type-1 Polarized Dendritic Cell (αDC1) Vaccine in Combination With Tumor-Selective Chemokine Modulation (Interferon-α2b, Rintatolimod, and Celecoxib) in Subjects With Chemo-Refractory Metastatic Colorectal Cancer
- Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer
- Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine
- Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer
- Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods)
- Effects of Chronic Viral Infection on Immune Response to Zoster Vaccination
- Pilot Study to Assess Safety, Preliminary Efficacy and Pharmacokinetics of S.C. Pegcetacoplan (APL-2) in PNH Subjects.
- Pilot Study of Vigil™ + Pembrolizumab for Advanced Melanoma
- HSV529 Vaccine in HSV-2 Seropositive Adults
- The Effect of Influenza Vaccination on the Systemic Inflammatory Response and Myocardial Protection in Patients Undergoing Cardiac Surgery: a Randomized Controlled Trial
- Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis.
- A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers
- Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of UB-311 in Mild Alzheimer's Disease (AD) Patients
- Efficacy & Safety of Nasal Influenza Immunisation in Children
- A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.
- Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients
- A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis
- PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCC
- Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study
- Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
- Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
- Intradermal Rabies Immunization Using NanoJect: A Comparative Study
- Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation Study
- Nivolumab With DC Vaccines for Recurrent Brain Tumors
- Pertussis and Meningitis C Concomitant Vaccination in Adolescents
- Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Safety Study of a Helper Peptide Vaccine Plus Pembrolizumab
- Evaluating New Formulation of Therapeutic HSV-2 Vaccine
- Pertussis Immunization During Pregnancy: Effect in Term and Preterm Infants
- A Two-part Phase IIb Trial of Vigil in Ewing's Sarcoma
- Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual B...
- Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
- Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma
- Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer
- Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues Therapy
- Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic
- Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer
- A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults
- A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults
- Type I-Polarized Autologous Dendritic Cell Vaccine With Tumor Blood Vessel Antigen-Derived Peptides in Metastatic Breast Cancer Patients
- Effect of Obesity on Immune Response to Pneumovax 23
- Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung
- Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
- SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
- Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas
- Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy
- Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma
- Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas
- Neoadjuvant GMCI Plus Chemoradiation for Advanced Non-Metastatic Pancreatic Adenocarcinoma
- ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors
- A Trial Investigating the Influence of BCG and Hepatitis B Immunisation at Birth on Neonatal Immune Responses: The Early Life Vaccines and Immunity Study
- Grass Pollen Subcutaneous Immunotherapy in Elderly Patients
- A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad35.RSV.FA2 Regimens Boosted With Ad26.RSV.FA2 in Healthy Adult Participants
- A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
- A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses
- Effects of Persistent Innate Immune Activation on Vaccine Efficacy
- Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
- Safety Study of a Helper Peptide Vaccine Plus Adjuvant Combinations for the Treatment of Melanoma
- Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination
- Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
- Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)
- A Study of Varlilumab (Anti-CD27) and Ipilimumab and CDX-1401 in Patients With Unresectable Stage III or IV Melanoma
- Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy
- Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer
- Vaccination in Prostate Cancer (VANCE)
- Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
- A Phase I/II Trial to Evaluate a Peptide Vaccine Plus Ipilimumab in Patients With Melanoma
- A Clinical Trial to Evaluate a Melanoma Helper Peptide Vaccine Plus Dabrafenib and Trametinib
- Heterologous Effects of BCG in Healthy UK Adults
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women
- Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis
- VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer
- Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric Participants
- DC Migration Study for Newly-Diagnosed GBM
- A Phase I Study of a Therapeutic Vaccine Candidate in Patients With Localized Breast Cancer at High-Risk of Relapse
- Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein
- Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients
- Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix
- Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)
- Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed
- A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS
- Research In Viral Eradication of HIV Reservoirs
- SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy
- Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali
- Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs
- A Study of DPX-Survivac Vaccine Therapy in Patients With Recurrent Survivin-expressing DLBCL
- MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery
- Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
- Prevention for Mother-to-infant Transmission of HBV
- A Randomized Prospective Clinical Trial of Fel d 1 Peptide Immunotherapy
- Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis
- TP10 Use in Patients With C3 Glomerulopathy (C3G)
- Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants
- The Effect of Anti-viral Drugs Used in Late Pregnancy on Long-term Development of Children
- Phase IIB TL + YCWP + DC in Melanoma
- Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia
- A Study to Evaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults
- Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients
- Phase II Study to Assess Safety & Immunogenicity of Multimeric-001 Influenza Vaccine, Followed by TIV
- Safety Study of Vx006 Vaccine in Solid Tumor Patients
- Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers
- Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma
- p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer
- Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients
- Trial on the Ideal Duration of Oral Antibiotics in Children With Pneumonia
- Efficacy of Antiviral Therapy in Pregnancy in Preventing Vertical Transmission of HBV in Mothers With a High Viral Load
- A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
- Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis B
- RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
- GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab
- Pilot Study of DRibble Vaccine for Prostate Cancer Patients
- Banlangen Granules Anti-seasonal Influenza Study
- Vaccination of High Risk Breast Cancer Patients
- Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC)
- H7N9 Mix and Match With MF59 in Healthy Elderly Persons
- The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine
- Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)
- Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHU
- Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy
- IDH1 Peptide Vaccine for Recurrent Grade II Glioma
- Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)
- An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate
- Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID
- Rotavirus vs. Sucrose for Vaccine Injection Pain
- DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
- Pilot Study of Interferon Alfa for Patients Who Have Received Cancer Vaccines
- Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination
- Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics
- Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Children
- Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination
- αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies
- GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients
- A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate
- A Trial Comparing Two Pertussis-containing Vaccines in Pregnancy and Vaccine Responses in UK Mothers and Their Infants
- A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1
- Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults
- Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial Cancers
- Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome
- Study of the Therapeutic Vaccine (ISA101/ISA101b) to Treat Advanced or Recurrent Cervical Cancer
- Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response
- Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine
- Safety of Nasal Influenza Immunisation in Egg Allergic Children - The SNIFFLE 2 Study
- Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer
- An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients
- Intradermal Influenza Vaccine in the Young
- Chemoprophylaxis and Plasmodium Falciparum NF54 Sporozoite Immunization Challenged by Heterologous Infection
- Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.
- Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir
- A Clinical Challenge Study of BCG in Healthy Volunteers
- HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)
- Target Antigens Induced by Plasmodium Falciparum Sporozoite Immunization Under Chemoprophylaxis
- Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme
- A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstructio
- Evaluation of Safety, Immunogenicity, and Prevention of TB With AERAS-404 and BCG Revaccination in Healthy Adolescents
- Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
- Enhancement by Poly-ICLC During HIV-1 Infection
- Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies
- Safety Study of a Capsule-Conjugate Vaccine to Prevent Campylobacter-Caused Diarrhea
- Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC FLU®Pre-filled Syringe Injection and 'GC FLU®Injection' Administration.
- T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma
- Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant
- The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults
- Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum
- Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
- Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias
- Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy Subjects
- 18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease
- Efficacy of Ondansetron on Vomiting Due to Acute Gastroenteritis in Pediatric During Winter
- Efficacy of Mw Vaccine in Treatment of Severe Sepsis
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting
- Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults
- Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults
- Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission
- Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab
- In Situ Vaccine for Low-Grade Lymphoma: Combination of Intratumoral Flt3L and Poly-ICLC With Low-Dose Radiotherapy
- A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive Donor
- Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive Melanoma
- Phase I Study of Safety and Immunogenicity of ADU-623
- Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults
- SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
- Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma
- Adolescent Vaccination in Pharmacies
- Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
- iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma
- Safety and Efficacy Study of Adjuvanted Prophylactic Hepatitis B Vaccine
- T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma
- Influenza Vaccine To Prevent Adverse Vascular Events:Pilot
- H7N9 Mix and Match With AS03 and MF59 in Healthy Adults
- VACcination In Methotrexate Treated Rheumatoid Arthritis Patients
- H7N9 Mix and Match With MF59 in Healthy Adults
- Efficacy Study of Vx001 Vaccine in NSCLC Patients
- Self-Administered Nasal Influenza Feasibility Study
- Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)
- Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia
- Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda
- Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer
- Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines
- Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients
- FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer
- Pneumococcal Vaccine in Untreated CLL Patients
- The Treatment With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg Seroconversion
- A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)
- Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma
- Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer
- Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer
- Salvage Ovarian FANG™ Vaccine + Carboplatinum
- Immune Response To Intranasal Influenza Vaccination
- Therapeutic Vaccine for HIV
- Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis
- Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
- IPV Clinical Trial - The Gambia
- Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission
- Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
- WT1 Analog Peptide Vaccine in Patients With Multiple Myeloma Following Autologous Stem Cell Transplantation
- New Methods to Measure the Immune Response to Hepatitis B Vaccine
- Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
- Individualized vs. Household MRSA Decolonization
- Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E
- Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
- Dendritic Cell Vaccine for Children and Adults With Sarcoma
- A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma
- Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy
- Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells
- GVAX vs. Placebo for MDS/AML After Allo HSCT
- Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers
- Phase 1b Study Investigating Safety & Immunogenicity of TDV Given Intradermally by Needle or Needle-Free PharmaJet Injector
- Pneumococcal Protein Vaccine Safety and Immunogenicity Trial
- Field Application of Shanchol in Adults in Bangladesh
- Ciprofloxacin BioThrax Co-Administration Study
- LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine
- Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery
- Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand
- Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients
- Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists
- Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients
- Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac
- Safety and Immunogenicity of a New Inactivated Poliovirus Vaccine in Infants
- Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults
- Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)
- A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
- Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies
- A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer
- Phase II Randomized Trial of Ipilimumab Versus Ipilimumab and Radiotherapy in Metastatic Melanoma
- Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes
- Efficacy and Safety of Influenza Vaccine During Sarcoidosis
- Intradermal Versus Intramuscular Polio Vaccine Booster in HIV-Infected Subjects
- A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers
- Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas
- Phase 2 Reduction of Dietary Mycotoxin Exposure by ACCS100"
- Evaluating Immune Response to Seasonal FluMist in Healthy Adults
- Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
- A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma
- Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season
- Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer
- Telbivudine Therapy in HBeAg-positive Pregnant Women to Prevent Mother-to-infant Transmission of HBV
- Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART
- Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis.
- Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide
- Pancreatic Tumor Cell Vaccine (GVAX), Low Dose Cyclophosphamide, Fractionated Stereotactic Body Radiation Therapy (SBRT), and FOLFIRINOX Chemotherapy in Patients With Resected Adenocarcinoma of the Pancreas
- Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer
- Safety Study of FluMist With and Without Ampligen
- Pakistan Short Interval mOPV1 Compared With Standard Interval mOPV1 and bOPV 1,3
- Vemurafenib and White Blood Cell Therapy for Advanced Melanoma
- Investigation of the Influence of Gender on Cardiovascular Function
- Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer
- H5N1 Vaccination With and Without AS03: Systems Biology Analysis
- A Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAART
- Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax
- A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma
- Study of DC Vaccination Against Glioblastoma
- Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43
- Salvage Ovarian FANG™ Vaccine + Bevacizumab
- Pilot Immunotherapy Trial for Recurrent Malignant Gliomas
- Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine
- Sanaria™ PfSPZ Challenge Vaccine
- Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer
- Peptide Vaccine and Temozolomide for Metastatic Melanoma Patients
- A Comparison of the Safety and Immunogenicity of Various Schedules of Dengue Vaccine in Healthy Adult Volunteers
- Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
- Standard Dose Versus High-Dose Inactivated Flu Vaccine in Pediatric Solid Organ Transplant Patients
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
- Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot
- Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis Patients
- Intradermal Trivalent Influenza Vaccine With Imiquimod
- Tecemotide (L-BLP25) in Rectal Cancer
- Safety of Zostavax Vaccination in Rheumatoid Arthritis
- Randomized Phase II Adjuvant Chemotherapy ± FANG™ in Colorectal Carcinoma With Liver Metastases
- Immune Memory After Papillomavirus Vaccination
- Malaria Challenge in Healthy Volunteers
- A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
- Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients
- Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis
- Impact of Raltegravir Intensification on HIV-1-infected Subjects With Complete Viral Suppression Under Monotherapy With Protease Inhibitors
- Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
- Zostavax in Systemic Lupus Erythematosus
- Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females
- Study to Evaluate Safety, Tolerability, PK and PD of ALXN1007 in Healthy Subjects
- Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy
- Dendritic Cell Vaccination and Docetaxel for Patients With Prostate Cancer
- PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine
- Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma
- Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer
- Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer
- Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer
- Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ Mothers
- A Feasibility and Safety Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells in Patients With Metastatic, Locally Advanced, Unresectable, or Recurrent Pancreatic Adenocarcinoma
- Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide
- Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma
- Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma
- Shigella Sonnei OSPC-rDT Conjugate Vaccine
- Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)
- The Effects of GLA on Human Volunteers
- Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13®
- Trial to Assess the Impact of PrEP to Tenofovir Gel on the Efficacy of Tenofovir-containing ART on Viral Suppression
- CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors
- Strategies for Enhancing Mucosal Immunity to Influenza Vaccine
- PPSV23 Pneumococcal Vaccine in Chronic Obstructive Pulmonary Disease (COPD)
- Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study
- Safety Study of Single Administration Intravenous Treatment for Influenza
- Safety Study of a Rotavirus Vaccine (Rotavin-M1) Among Healthy Adults
- NASVAC Phase-III Trial in Chronic Hepatitis B (CHB) Patients
- Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant Psoriasis
- Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer
- Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine
- Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus
- Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission
- Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal
- Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma
- Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy
- CHRONVAC-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) Subjects
- Safety and Pharmacokinetics of TT30 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients
- Safety and Tolerability of the Derma Vax(Trademark) Clinical Intradermal Electroporation System in Healthy Subjects
- H5N1 Mix and Match With AS03
- H5N1 Mix and Match With MF59
- Safety and Efficacy of CJ Smallpox Vaccine in Previously Vaccinated Healthy Volunteers
- Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum
- Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer
- C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast Cancer
- Polyinosinic-Polycytidylic Acid-poly-L-lysine Carboxymethylcellulose (Poly-ICLC) in Healthy Volunteers
- Montelukast for Persistent Cough in Young People and Adults
- Immunomodulating Therapy and Improved Vaccination Responses by Cox-2 Inhibitor in HIV-infected Patients
- HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)
- IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma
- Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma
- Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults
- Llama Antibody, Rotavirus Diarrhoea, Children
- Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas
- Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults
- Modified Vaccinia Ankara (MVA) Vaccine Study
- Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma
- Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma
- Swine Flu (Influenza A H1N1) Follow on Vaccine Study
- Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment
- Post-Exposure Prophylaxis in Health Care Workers
- Effect of Zinc Supplementation on Response to Oral Polio Vaccine in Infants in Pakistan
- A Study, Combination, Immunologic Study of LTX-315 as Adjunct to GV1001 in Patients Following Curative Surgery for Carcinoma
- Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer
- Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV-1 Infected Persons
- Standard Versus High-Dose Trivalent Inactivated Flu Vaccine in Pediatric Acute Lymphoblastic Leukemia Patients
- Dendritic Cell Cancer Vaccine for High-grade Glioma
- Relenza® Sentinel Site Monitoring Program in Japan
- TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
- Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma
- Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma
- Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma
- Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558
- Pneumococcal Vaccines Early and in Combination
- Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant
- Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
- EP1300 Polyepitope DNA Vaccine Against Plasmodium Falciparum Malaria
- Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma
- Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 Adjuvant
- A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults
- Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver
- Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
- Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas
- HIV-1 Peptide Immunisation of Individuals in West Africa to Prevent Disease
- A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
- Novel Interventions in HIV-1 Infection
- DCVax Plus Poly ICLC in Healthy Volunteers
- Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination
- An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
- Tetravalent Chimeric Dengue Vaccine Trial
- Study of Tecemotide (L-BLP25) in Subjects With Slowly Progressive Multiple Myeloma With no Symptoms and Who Have Had no Chemotherapy
- A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study)
- Safety and Immunogenicity Study of Plasmodium Vivax CS Derived Synthetic Peptides Formulated in Two Adjuvants
- Immunotherapy Study for Surgically Resected Pancreatic Cancer
- Auto-immunity in Lupus Patients After Influenza Vaccine
- Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation
- Safety Study of DNA Vaccine Delivered by Intradermal Electroporation to Treat Colorectal Cancer
- Safety and Efficacy of CJ Smallpox Vaccine in Healthy Volunteers
- Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV Patients
- A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S. Mansoni
- Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma
- Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer
- QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer
- A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
- A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
- A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine
- Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients
- EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-immune Adults
- A Study to Assess DV-601 in Subjects With Chronic Hepatitis B
- Efficacy Safety Study of Flu Vaccine in Immunodepression Patients
- Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children
- Studies of Immune Responses to Orally Administered Vaccines in Developing Country
- Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkina Faso
- Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian Population
- Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors
- A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis
- Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100
- Comparison of Different Methods for Reducing Pain From Influenza Vaccine Injections
- Nicotine Vaccination and Nicotinic Receptor Occupancy
- Efficacy and Safety of NicVAX® Co-administered With Varenicline (Champix®)
- Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
- Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir
- Phase I STEBVax in Healthy Adults
- Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose
- Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer
- Multisite Controlled Trial of Cocaine Vaccine
- Rapid Evaluation of Seasonal Influenza Vaccine
- Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination
- Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations
- Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia
- Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy Adults
- Trial for Vaccine Therapy With Dendritic Cells in Patients With Metastatic Malignant Melanoma
- Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist
- Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy
- Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer
- Vaccine Biotherapy of Cancer: Autologous Tumor Cells and Dendritic Cells
- Sanofi H1N1 + TIV - Adults and Elderly
- Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies
- The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata
- Complement Inhibition With Eculizumab for the Treatment of Non-Exudative Macular Degeneration (AMD)
- Dendritic Cell Based Therapy for Breast Cancer Patients
- Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Pa
- STRIDE - STimulating Immune Response In aDvanced brEast Cancer
- Safety, Tolerability and Pharmacodynamics of CYT013-IL1bQb in Patients With Type 2 Diabetes
- An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing
- Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
- Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma
- Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma
- Safety and Immunogenicity Study of Intramuscular CCS/C-adjuvanted Influenza Vaccine in Elderly
- Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients
- Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59
- Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Study
- Autologous Dendritic Cells Pulsed With Autologous Apoptotic Tumor Cells Administered to Patients With Brain Tumors
- Phase I Study of the Safety and Immunogenicity of BSAM-2/Alhydrogel +CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria in Adults in the US and Mali
- High Dose IMVAMUNE® in Vaccinia-Naive Individuals
- MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer
- DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma
- Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide Vaccine
- VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactiva
- Study of the Effect of Probiotics on Respiratory Morbidity After Influenza Vaccination of Elderly in Nursing Homes
- Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer
- Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients
- p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer
- Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)
- A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients
- Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
- Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer
- BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
- Long-term Efficacy and Safety Study With Oralgen Grass Pollen
- Randomized, Double Blind, Placebo-controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination
- Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease
- Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home
- A Controlled Clinical Trial on The Use of a Specific Antivenom Against Envenoming by Bungarus Multicinctus
- Phase 1 Norwalk Vaccine Study
- Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease
- Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis
- Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod
- Vaccine Therapy in Treating Patients With Stage IV Breast Cancer
- Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3
- Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
- IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)
- Zanamivir Versus Trivalent Split Virus Influenza Vaccine
- Vaccine for Prevention of Bird Flu
- Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
- Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer
- Intermittent Preventive Treatment in Infant in Mali
- A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma
- Tolerance and Efficacy of Rituximab in Sjogren's Disease
- Malaria Vaccine for Children in Mali
- Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery
- A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer
- Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitis
- Vaccine Therapy in Preventing Cytomegalovirus in Healthy Participants
- Single DermaVir Immunization in HIV-1 Infected Patients on HAART
- Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector Injection
- Oseltamivir Randomised Controlled Efficacy Trial
- Pertussis Vaccine in Healthy Pregnant Women
- Effect of Levamisole Supplementation on Tetanus Vaccination Response Rates in Hemodialysis Patients
- Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer
- Ovarian Dendritic Cell Vaccine Trial
- PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment
- Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma
- Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer
- Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms
- Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)
- Study of Colon GVAX and Cyclophosphamide in Patients With Metastatic Colorectal Cancer
- Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)
- Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients
- Safety and Immunogenicity of Peru-15-pCTB in Healthy Adult Subjects
- Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer
- Effect of the Interferon Alpha Citizen by Sub-Lingual Way on the Humoral Immunizing Answer
- Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes
- Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Varicella Vaccination With Pulmicort
- A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children
- Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia
- Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery
- Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer
- Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12
- Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma
- Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis
- To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid
- Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma
- Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma
- Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection
- Ebola and Marburg Virus Vaccines
- Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer
- Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients
- Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer
- Bone Marrow Transplantation, Hemoglobinopathies, SCALLOP
- Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
- A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
- Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer
- Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma
- Safety, Reactogenicity and Immunogenicity of MVA in Hematopoietic Stem Cell Transplant (HSCT) Subjects
- Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients
- Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients
- Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy
- Kabul Vitamin D Supplementation Trial
- Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults
- Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs
- SARS Coronavirus Vaccine (SARS-CoV)
- A Study of Mycobacterium w Plus Docetaxel for Hormone Refractory Metastatic Prostate Cancer
- IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease
- Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer
- Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)
- Study of NY-ESO-1 ISCOMATRIX® in Patients With Measurable Stage III or IV Melanoma
- Vaccination Plus Ontak in Patients With Metastatic Melanoma
- Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine
- Phase I Study to Investigate the Safety and Efficacy of HBV DNA Vaccine
- Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma
- Mass-Drug Administration to Reduce Malaria Transmission
- Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBV
- Chiron Corp HCV E1/E2 Vaccine
- Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A
- Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis
- Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL
- Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally
- Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers
- Phase 1 Study of the Safety, Reactogenicity, and Immunogenicity of AMA1-C1/ISA 720: Blood Stage Vaccine for Plasmodium Falciparum
- Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.
- Phase 1 Safety Study of Two Experimental HIV Vaccines
- Vaccine Therapy and Resiquimod in Treating Patients With Stage II, Stage III, or Stage IV Melanoma That Has Been Completely Removed by Surgery
- Vanderbilt Pertussis Exposure Study: PEP in Vaccinated Healthcare Workers Following Pertussis Exposure
- Phase 2 Study of Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Smallpox Vaccine
- Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF
- Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
- Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin
- Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma
- Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer
- TG4040 in Patients With Chronic HCV
- Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Higher Dose Intradermal H5 Vaccine
- Tetanus Immunization in Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective Levels
- MVA Post-Event: Administration Timing and Boost Study
- Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy
- Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis C
- Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria Vaccine
- Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
- Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
- Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R)
- Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer
- Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria
- Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)
- Safety Study of Avian Flu Vaccine
- Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer
- Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease
- BCG Vaccination Delivered Intradermally, Orally and by Combined Routes
- Th1 Response to Influenza: Aging and Vaccine Efficacy
- Does the Order in Which Vaccines Are Administered Affect Pain Response?
- Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
- Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in Adults
- Vitamin D Dose-Response Study to Establish Dietary Requirements in Infants
- B-19 Parvovirus Vaccine Study
- Mercury Chelation to Treat Autism
- Efficacy of Sambucol in the Treatment of Influenza
- Experimental Vaccine for Prevention of Ebola Virus Infection
- MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate Cancer
- A Study on Immunological Effect of Vitamin A and Zinc in a Placebo Controlled 4 Cell Trial
- Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
- Adenovirus Vaccine for Malaria
- Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants
- Enteroaggregative E.Coli (EAEC)
- Effect of Montelukast on Experimentally-Induced RV16 Infection in Asthma
- Efficacy Trial on Oral Miltefosine in Comparison With Glucantime in the Treatment of ACL Caused by L. Tropica
- Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly
- DNA Vaccine for Ragweed Allergic Adults
- Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic Leukemia
- Experimental Vaccine for Malaria in Adults in Mali
- Malaria Vaccine in Children in Mali
- Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark)
- Experimental Vaccine for Plasmodium Falciparum Malaria
- Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer
- CVD 909 Vi Prime Boost Study
- Study To Evaluate the Safety of Bivalent Vaccine
- GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
- Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma
- Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine
- Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients
- Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme
- Phase I Study of Vaccination Schedule of Experimental HIV Vaccines
- Dendritic Cell Vaccination During Lymphoid Reconstruction
- Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
- Vaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic Melanoma
- SIGA-246 to Treat Smallpox
- Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
- Study on Preventing Anemia in Children in Ghana
- Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer
- Phase I Study of West Nile Virus Vaccine
- CMV Glycoprotein B Vaccine in Allograft Recipients
- H5 Vaccine Alone or With Adjuvant in Healthy Adults
- PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria
- Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines
- Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected Patients
- A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate
- Safety and Immunogenicity Study of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Infants
- H5 Adult - Chiron Study of Bird Flu Vaccine
- Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine
- Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma
- Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients
- Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome
- TY800 Dose Escalation (Typhoid)
- Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
- Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection
- Efficacy of Bifidus DR10 and Oligo Saccharides / Micronutrient Fortification of Milk
- Melanoma Vaccine With Peptides and Leuprolide
- Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised
- Inactivated Influenza A/H5N1 Vaccine in the Elderly
- Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated Wit
- S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission
- Lymphocytic B-Leukemia (B-CLL) w/Human IL-2 Gene Modified & Human CD40 Ligand-Expressing Autologous Tumor Cells
- Influenza Vaccination and Oral Anticoagulant Therapy
- Influenza Vaccine in Lung Transplant Patients
- Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma
- Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma
- Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients
- Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer
- Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine
- Different Doses of Vitamin A Supplementation and Male and Female Morbidity and Mortality
- Vitamin A Supplementation With Routine Childhood Vaccines and Mortality and Morbidity
- Vitamin A Supplementation With Bacille Calmette Guerin (BCG) Vaccine
- Vitamin A With BCG Vaccine
- Different Doses of Vitamin A and Childhood Morbidity and Mortality
- Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants
- Kilimanjaro IPTi Drug Options Trial
- Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding
- Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer)
- Safety Study of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III Disease
- NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)
- A Study of Anti-CTLA4 Antibody in People With Advanced Synovial Sarcoma
- Immune Dysregulation in Children and Adults With Asthma
- Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma
- 9-valent CRM 197 Pneumococcal
- A/H5N1 Vaccine in Healthy Children Aged 2-9 Years
- gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females
- Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults
- Pentavalent DTaP-Hep B-IPV
- Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients
- A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case Contacts
- Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age
- Recombinant CMV gB Vaccine in Postpartum Women
- Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine
- Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)
- Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma
- Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma
- Anthrax Vaccine Clinical Trials
- Experimental Vaccine for Malaria
- Vaccine and Antibody Treatment of Prostate Cancer
- Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA)
- "Prime-Boost" Vaccine Schedule for Prevention of HIV Infection
- A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer
- Vaccine Treatment for HIV-Infection
- Vaccine to Prevent West Nile Virus Disease
- Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment
- HIV-1 Vaccine Booster in Previously Immunized Uninfected Adult Volunteers
- Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma
- Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia
- Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa
- Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People
- RSV Challenge in Healthy Adults
- Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS)
- Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
- A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therap
- Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
- Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)
- MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
- Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer
- Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer
- Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma
- Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma
- Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery
- GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
- Vaccine Treatment of Kidney Cancer
- A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC)
- Candidate HIV Vaccine
- Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma
- Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer
- Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer
- PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer
- Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma
- Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma
- Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers
- Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors
- A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma
- Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma
- Lymphocyte-Depleting Nonmyeloablative Preparative Chemotherapy Followed By Autologous Lymphocyte Infusion, Peptide Vaccine Plus Montanide ISA-51, and Interleukin-2 in Treating Patients With Metastatic Melanoma
- Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer
- Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP
- Experimental Ebola Vaccine Trial
- Vitamin A Supplementation in Preterm Infants
- Sequential Vaccinations in Prostate Cancer Patients
- Peptide Vaccination for Patients at High Risk for Recurrent Melanoma
- Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV
- Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox
- Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer
- Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2
- Safety/Efficacy of a Vaccine Prepared From Dendritic Cells Combined With Tumor Cells to Treat Advanced Kidney Cancer
- Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer
- HIV-1 Vaccine Test in Uninfected Adult Volunteers
- Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma
- Phase I Trial of Smallpox Vaccine
- Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients
- HIV-1 Vaccine Test in Uninfected Adult Volunteers
- S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer
- Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer
- Study of Anti-HIV Therapy Intensification
- Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma
- Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin
- Increasing HAART-Induced Immune Restoration With Cyclosporine
- Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
- Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer
- An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV
- Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC
- Chemotherapy, Vaccine Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Multiple Myeloma
- Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
- Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye
- Vaccine Therapy in Treating Patients With Metastatic Cancer
- Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer
- Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma
- Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma
- Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
- flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer
- Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
- Vaccine Therapy in Treating Patients With Multiple Myeloma
- Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
- Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma
- Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery
- Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer
- Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load
- HIV-1 Vaccine Test in Uninfected Adult Volunteers
- Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
- Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection
- Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination
- Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma
- Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma
- PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer
- Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma
- Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy
- Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)
- Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
- Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy
- Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
- Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma
- Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma
- Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma
- Vaccine Therapy in Treating Women With Metastatic Breast Cancer
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
- Methylphenidate in Treating Patients With Melanoma
- Biological Therapy in Treating Patients With Glioblastoma Multiforme
- Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer
- Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
- A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART
- Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype
- A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas
- A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas
- Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation
- Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines
- Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy
- Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV
- A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected Volunteers
- A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers
- Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals
- A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection
- A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients
- A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells
- A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy
- A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3
- Vaccination With Tetanus and KLH to Assess Immune Responses.
Clinical trials list
click for details